Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt Global regulators commit to cooperate on observational research in the context of COVID-19 20 maj 2020Press releaseHumanCOVID-19Research and development Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #2 18 maj 2020NewsHumanCOVID-19Clinical trialsMedicine shortages EU actions to support availability of medicines during COVID-19 pandemic – update #6 15 maj 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials 15 maj 2020Press releaseHumanCOVID-19Clinical trials Update of EU recommendations for 2020/2021 seasonal flu vaccine composition 15 maj 2020NewsHumanMedicinesVaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 May 2020 15 maj 2020NewsHumanPharmacovigilanceReferrals Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors 15 maj 2020Press releaseHumanPharmacovigilanceReferrals EMA recommends expanding remdesivir compassionate use to patients not on mechanical ventilation 11 maj 2020NewsHumanCompassionate useMedicines for use outside the EU EU actions to support availability of medicines during COVID-19 pandemic – update #5 8 maj 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 5 maj 2020NewsHumanCOVID-19 1 … 85 86 87 88 89 Page 89 of 383 90 91 92 93 … 383
Global regulators commit to cooperate on observational research in the context of COVID-19 20 maj 2020Press releaseHumanCOVID-19Research and development
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #2 18 maj 2020NewsHumanCOVID-19Clinical trialsMedicine shortages
EU actions to support availability of medicines during COVID-19 pandemic – update #6 15 maj 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages
International coordination needed to encourage conduct of large, decision-relevant COVID-19 clinical trials 15 maj 2020Press releaseHumanCOVID-19Clinical trials
Update of EU recommendations for 2020/2021 seasonal flu vaccine composition 15 maj 2020NewsHumanMedicinesVaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 May 2020 15 maj 2020NewsHumanPharmacovigilanceReferrals
Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors 15 maj 2020Press releaseHumanPharmacovigilanceReferrals
EMA recommends expanding remdesivir compassionate use to patients not on mechanical ventilation 11 maj 2020NewsHumanCompassionate useMedicines for use outside the EU
EU actions to support availability of medicines during COVID-19 pandemic – update #5 8 maj 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 5 maj 2020NewsHumanCOVID-19